Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bioidentical hormone micronized progesterone.

× No keyword cloud information.

14 in total

Review 1. Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors: D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal: Ann Intern Med Date: 1992-12-15 Impact factor: 25.391

2. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Authors: M J Stampfer; G A Colditz
Journal: Prev Med Date: 1991-01 Impact factor: 4.018

3. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.

Authors: Etta A Lindenfeld; Robert D Langer
Journal: Obstet Gynecol Date: 2002-11 Impact factor: 7.661

4. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.

Authors: J T Hargrove; W S Maxson; A C Wentz; L S Burnett
Journal: Obstet Gynecol Date: 1989-04 Impact factor: 7.661

Review 5. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.

Authors: Heidi D Nelson; Kimberly K Vesco; Elizabeth Haney; Rongwei Fu; Anne Nedrow; Jill Miller; Christina Nicolaidis; Miranda Walker; Linda Humphrey
Journal: JAMA Date: 2006-05-03 Impact factor: 56.272

6. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women.

Authors: G M Rosano; C M Webb; S Chierchia; G L Morgani; M Gabraele; P M Sarrel; D de Ziegler; P Collins
Journal: J Am Coll Cardiol Date: 2000-12 Impact factor: 24.094

7. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey.

Authors: L A Fitzpatrick; C Pace; B Wiita
Journal: J Womens Health Gend Based Med Date: 2000-05

8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors:
Journal: JAMA Date: 1995-01-18 Impact factor: 56.272

9. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal: JAMA Date: 2002-07-17 Impact factor: 56.272

10. Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women.

Authors: Jennifer A Cummings; Louann Brizendine
Journal: Menopause Date: 2002 Jul-Aug Impact factor: 2.953

1 in total

1. Bioidentical hormone therapy.

Authors: Elisabeth Gold
Journal: Can Fam Physician Date: 2012-12 Impact factor: 3.275

1 in total